Free Trial
NASDAQ:DCTH

Delcath Systems (DCTH) Stock Price, News & Analysis

Delcath Systems logo
$10.80 -0.30 (-2.70%)
Closing price 04:00 PM Eastern
Extended Trading
$10.71 -0.09 (-0.83%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Delcath Systems Stock (NASDAQ:DCTH)

Advanced

Key Stats

Today's Range
$10.72
$11.40
50-Day Range
$10.01
$11.75
52-Week Range
$8.08
$18.23
Volume
822,507 shs
Average Volume
585,916 shs
Market Capitalization
$377.78 million
P/E Ratio
216.00
Dividend Yield
N/A
Price Target
$24.50
Consensus Rating
Moderate Buy

Company Overview

Delcath Systems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

DCTH MarketRank™: 

Delcath Systems scored higher than 55% of companies evaluated by MarketBeat, and ranked 497th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Delcath Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Delcath Systems has a consensus price target of $24.50, representing about 127.4% upside from its current price of $10.78.

  • Amount of Analyst Coverage

    Delcath Systems has only been the subject of 2 research reports in the past 90 days.

  • Read more about Delcath Systems' stock forecast and price target.
  • Earnings Growth

    Earnings for Delcath Systems are expected to grow in the coming year, from ($0.79) to ($0.41) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Delcath Systems is 215.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.47.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Delcath Systems is 215.70, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 85.70.

  • Price to Book Value per Share Ratio

    Delcath Systems has a P/B Ratio of 5.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Delcath Systems' valuation and earnings.
  • Percentage of Shares Shorted

    9.15% of the outstanding shares of Delcath Systems have been sold short.
  • Short Interest Ratio / Days to Cover

    Delcath Systems has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Delcath Systems has recently increased by 5.26%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Delcath Systems does not currently pay a dividend.

  • Dividend Growth

    Delcath Systems does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.15% of the outstanding shares of Delcath Systems have been sold short.
  • Short Interest Ratio / Days to Cover

    Delcath Systems has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Delcath Systems has recently increased by 5.26%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Delcath Systems has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Delcath Systems this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    Only 3 people have added Delcath Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Delcath Systems insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.94% of the stock of Delcath Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    61.12% of the stock of Delcath Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Delcath Systems' insider trading history.
Receive DCTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DCTH Stock News Headlines

Delcath Systems (NASDAQ:DCTH) Upgraded at Wall Street Zen
URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
Craig-Hallum Remains a Buy on Delcath Systems (DCTH)
See More Headlines

DCTH Stock Analysis - Frequently Asked Questions

Delcath Systems' stock was trading at $12.04 at the beginning of the year. Since then, DCTH shares have decreased by 10.5% and is now trading at $10.7750.

Delcath Systems, Inc. (NASDAQ:DCTH) released its quarterly earnings results on Wednesday, August, 6th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.05. The firm earned $24.16 million during the quarter, compared to the consensus estimate of $22.84 million. Delcath Systems had a net margin of 3.18% and a trailing twelve-month return on equity of 6.91%.
Read the conference call transcript
.

Delcath Systems's stock reverse split on Tuesday, October 22nd 2019.The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 21st 2019. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of DCTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Delcath Systems investors own include Predictive Oncology (POAI), Ford Motor (F), JPMorgan Chase & Co. (JPM), Zomedica (ZOM), Wells Fargo & Company (WFC), Wayfair (W) and Bank of America (BAC).

Company Calendar

Last Earnings
8/06/2025
Today
10/06/2025
Next Earnings (Estimated)
11/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:DCTH
CIK
872912
Employees
60
Year Founded
1988

Price Target and Rating

High Price Target
$31.00
Low Price Target
$21.00
Potential Upside/Downside
+118.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.05
Trailing P/E Ratio
223.40
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.39 million
Net Margins
3.18%
Pretax Margin
4.18%
Return on Equity
6.91%
Return on Assets
5.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.88
Quick Ratio
9.87

Sales & Book Value

Annual Sales
$37.21 million
Price / Sales
10.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.15 per share
Price / Book
5.23

Miscellaneous

Outstanding Shares
34,980,000
Free Float
28,705,000
Market Cap
$393.07 million
Optionable
Optionable
Beta
0.84

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:DCTH) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners